Skip to content
10-Q

Quarterly Report

Cellcyte Genetics Corp.

0001056520-13-000247

← back to feed
Filed
Nov 14, 2013 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2013 · Nov 13, 2013 82.33M sh
Operating Cash Flow Q3 2013 · Sep 30, 2013 −$6.04M
Operating Cash Flow Q3 2013 · Sep 30, 2012 −$44.52K
Stockholders Equity Q3 2013 · Sep 30, 2013 −$773.85K
Stockholders Equity Q3 2013 · Sep 30, 2012 −$655.76K
Current Liabilities Q3 2013 · Sep 30, 2013 $415.77K
Current Liabilities restated Q3 2013 · Sep 30, 2012 $334.97K
Total Liabilities Q3 2013 · Sep 30, 2013 $801.52K
Total Liabilities Q3 2013 · Sep 30, 2012 $681.38K
Current Assets Q3 2013 · Sep 30, 2013 $17.07K
Current Assets restated Q3 2013 · Sep 30, 2012 $9.4K
Total Assets Q3 2013 · Sep 30, 2013 $27.66K
Total Assets restated Q3 2013 · Sep 30, 2012 $25.62K
Eps Diluted Q3 2013 · Sep 30, 2013 $0.00
Eps Diluted Q3 2013 · Sep 30, 2013 $0.00
Eps Diluted Q3 2013 · Sep 30, 2012 $0.00
Eps Diluted Q3 2013 · Sep 30, 2012 $0.00
Eps Basic Q3 2013 · Sep 30, 2013 $0.00
Eps Basic Q3 2013 · Sep 30, 2013 $0.00
Eps Basic Q3 2013 · Sep 30, 2012 $0.00
Eps Basic Q3 2013 · Sep 30, 2012 $0.00
Sga Expense Q3 2013 · Sep 30, 2013 $2.64M
Sga Expense Q3 2013 · Sep 30, 2012 $16.49K
Sga Expense Q3 2013 · Sep 30, 2012 $50.3K
Rd Expense Q3 2013 · Sep 30, 2013 $1.3M
Net Income Q3 2013 · Sep 30, 2013 −$12.64M
Net Income Q3 2013 · Sep 30, 2012 $59.79K
Shares Diluted Q3 2013 · Sep 30, 2012 82.33M sh
Shares Diluted Q3 2013 · Sep 30, 2012 88.96M sh